California Senate Bill SB 519, Legislation to Decriminalize Possession of Some Psychedelics, Put on Hold
California Senate Bill SB 519, authored by Senator Scott Wiener (D-San Francisco), was put on hold and will now become a two-year bill. The legislation that would decriminalize several psychedelic substances in the state – including psilocybin, psilocyn, methylenedioxymethamphetamine (MDMA), lysergic acid diethylamide (LSD), dimethyltryptamine (DMT), mescaline not from peyote, and ibogaine – for adults 21 and older. The bill remains eligible to move forward in 2022.
A statement released by Senator Wiener’s team said “[M]ore time was needed to lay educational groundwork with members and the public to ensure the bill’s success. Delaying full Assembly consideration of the bill until next year will allow the SB 519 coalition of advocates and supporters – which includes veterans who have used psychedelics to treat PTSD, parents whose children overcame addiction with psychedelic therapy, and physicians – to capitalize on the momentum from this year while building support in the Assembly for next year.”